---
layout: theophylline_style
title: PAI-1 aptamer
date: 2024-05-24 00:00:00
author: Jiaxin Zhao, Bichun Wu
categories: Aptamer
tags:
- Category:Mammalian
- GC:53.949999999999996
- GC:57.89
- Length:76
- Named:Serine protease inhibitor plasminogen activator inhibitor-1 (PAI-1)_SM-20
- Named:Serine protease inhibitor plasminogen activator inhibitor-1 (PAI-1)_WT-15
- Type:Proteins
- Year:2009
type: Proteins
---
<html>


<div class="side-nav">
<ul>
    <div class="side-nav-item"><li><a href="#timeline" style="color: #000000;">Timeline</a></li></div>
    <div class="side-nav-item"><li><a href="#description" style="color: #000000;">Description</a></li></div>
    <div class="side-nav-item"><li><a href="#SELEX" style="color: #000000;">SELEX</a></li></div>
    <div class="side-nav-item"><li><a href="#Structure" style="color: #000000;">Structure</a></li></div>
    <div class="side-nav-item"><li><a href="#ligand-recognition" style="color: #000000;">Ligand information</a></li></div>
    <div class="side-nav-item"><li><a href="#references" style="color: #000000;">References</a></li></div>
    </ul>
</div>



<p class="header_box" id="timeline">Timeline</p>
<div class="timeline">
  <div class="entry">
  <div class="title">
    <h3><a href="https://pubmed.ncbi.nlm.nih.gov/3930479/" target="_blank" style="color:#520049">1985</a></h3>
  </div>
  <div class="body">
    <p>Active PAI-1 effectively inhibits target proteases but is labile as it spontaneously converts to the latent form<sup>[<a href="#ref1" style="color:#520049">1</a>]</sup></p>
  </div>
 </div>
            
 <div class="entry">
  <div class="title">
    <h3><a href="https://pubmed.ncbi.nlm.nih.gov/2459123/" target="_blank" style="color:#520049">1988</a></h3>
  </div>
  <div class="body">
    <p>Active PAI-1 binds to the extracellular matrix protein, vitronectin, which is unable to bind inactive PAI-1 or PAI-1 in complex with its target proteases<sup>[<a href="#ref2" style="color:#520049">2</a>]</sup></p>
  </div>
 </div>
            
 <div class="entry">
  <div class="title">
    <h3><a href="https://pubmed.ncbi.nlm.nih.gov/8662688/" target="_blank" style="color:#520049">1996</a></h3>
  </div>
  <div class="body">
    <p>PAI-1 competes with integrins and uPAR for vitronectin binding, resulting in the detachment of cells from the extracellular matrix<sup>[<a href="#ref3" style="color:#520049">3</a>]</sup></p>
  </div>
 </div>
            
 <div class="entry">
  <div class="title">
    <h3><a href="https://pubmed.ncbi.nlm.nih.gov/9168821/" target="_blank" style="color:#520049">1997</a></h3>
  </div>
  <div class="body">
    <p>The binding of PAI-1 to vitronectin prevents integrins from binding to vitronectin and inhibits cell adhesion in some cells, particularly breast cancer cells<sup>[<a href="#ref4" style="color:#520049">4</a>]</sup></p>
  </div>
 </div>
            
 <div class="entry">
  <div class="title">
    <h3><a href="https://pubmed.ncbi.nlm.nih.gov/15138609/" target="_blank" style="color:#520049">2004</a></h3>
  </div>
  <div class="body">
    <p>PAI-1 has been proven responsible for the regulation of cellular adhesion and migration, and has been shown to interact with several extracellular matrix components<sup>[<a href="#ref5" style="color:#520049">5</a>]</sup></p>
  </div>
 </div>
            
 <div class="entry">
  <div class="title">
    <h3><a href="https://pubmed.ncbi.nlm.nih.gov/19284310/" target="_blank" style="color:#520049">2009</a></h3>
  </div>
  <div class="body">
    <p>Aptamer WT-15 is generated by SELEX<sup>[<a href="#ref6" style="color:#520049">6</a>]</sup></p>
  </div>
 </div>
</div>



<p class="header_box" id="description">Description</p>
<p>In 2009, Charlene M Blake et al. used the SELEX method to isolate the aptamer with high compatibility for the serine protease inhibitor plasminogen activator inhibitor-1 (PAI-1). They determined that aptamers WT-15 binds to PAI-1 in a region that spans the heparin- and vitronectin-binding domains, inhibiting the PAI-1/vitronectin interaction. The PAI-1 aptamer WT-15 demonstrates therapeutic potential as an antimetastatic agent and could possibly be used as an adjuvant to traditional chemotherapy for breast cancer<sup>[<a href="#ref6" style="color:#520049">6</a>]</sup>.<br></p>


<p class="header_box" id="SELEX">SELEX</p>
<p>In 2009, Charlene M Blake et al. generated aptamers that specifically bind to PAI-1 with high affinity (Kd < 4 nM) using SELEX . Through functional assays including mutagenesis studies, competition binding, chromogenic assays, and cell adhesion experiments, they determined that aptamers WT-15 binds to PAI-1 in a region that spans the heparin- and vitronectin-binding domains, inhibiting the PAI-1/vitronectin interaction<sup>[<a href="#ref6" style="color:#520049">6</a>]</sup>.<p>
<br>


<p class="header_box" id="Structure">Structure</p>
<p>The 2D structure of the figure is based on the prediction results of the RNA fold website by ribodraw tool to draw.<br></p>
<p>5'-GGGAGGACGAUGCGGAUCAACUCACCGUAGGUCUAGUGAGAACUUCAAGUCUACUCAGACGACUCGCUGAGGAUCC-3'</p>
<img src="/images/2D/WT-15_aptamer_2D.svg" alt="drawing" style="width:800px;display:block;margin:0 auto;border-radius:0;" class="img-responsive">
<div style="display: flex; justify-content: center;"></div>



<font ><p class="header_box" id="ligand-recognition">Ligand information</p>  

<p class="blowheader_box">SELEX ligand</p>
<p>Plasminogen activator inhibitor-1 (PAI-1) also known as endothelial plasminogen activator inhibitor (serpin E1) is a protein that in humans is encoded by the SERPINE1 gene. Elevated PAI-1 is a risk factor for thrombosis and atherosclerosis. PAI-1 is a serine protease inhibitor (serpin) that functions as the principal inhibitor of tissue-type plasminogen activator (tPA) and urokinase (uPA), the activators of plasminogen and hence fibrinolysis (the physiological breakdown of blood clots). It is a serine protease inhibitor (serpin) protein (SERPINE1).-----From Wiki</p>
<table class="table table-bordered" style="table-layout:fixed;width:auto;margin-left:auto;margin-right:auto;" >
  <thead>
      <tr>
        <th onclick="sortTable(0)">Name</th>
        <th onclick="sortTable(1)">Uniprot ID</th>
        <th onclick="sortTable(2)">Pfam</th>
        <th onclick="sortTable(3)">MW</th>
        <th onclick="sortTable(4)">Amino acids sequences</th>
        <th onclick="sortTable(5)">PDB</th>
        <th onclick="sortTable(6)">Gene ID</th>
      </tr>
  </thead>
    <tbody>
      <tr>
        <td name="td0">Serine protease inhibitor plasminogen activator inhibitor-1 (PAI-1)</td>
        <td name="td1"><a href="https://www.uniprot.org/uniprotkb/P05121/entry" target="_blank" style="color:#520049"><b>P05121</b></a></td>
        <td name="td2"><a href="https://www.ebi.ac.uk/interpro/entry/InterPro/IPR000215/" target="_blank" style="color:#520049"><b>IPR000215</b></a></td>
        <td name="td3">45.07 kDa</td>
        <td name="td4">MQMSPALTCLVLGLALVFGEGSAVHHPPSYVAHLASDFGVRVFQQVAQASKDRNVVFSPYGVASVLAMLQLTTGGETQQQIQAAMGFKIDDKGMAPALRHLYKELMGPWNKDEISTTDAIFVQRDLKLVQGFMPHFFRLFRSTVKQVDFSEVERARFIINDWVKTHTKGMISNLLGKGAVDQLTRLVLVNALYFNGQWKTPFPDSSTHRRLFHKSDGSTVSVPMMAQTNKFNYTEFTTPDGHYYDILELPYHGDTLSMFIAAPYEKEVPLSALTNILSAQLISHWKGNMTRLPRLLVLPKFSLETEVDLRKPLENLGMTDMFRQFQADFTSLSDQEPLHVAQALQKVKIEVNESGTVASSSTAVIVSARMAPEEIIMDRPFLFVVRHNPTGTVLFMGQVMEP</td>
        <td name="td5"><a href="https://www.rcsb.org/structure/4DTE" target="_blank" style="color:#520049"><b>4DTE</b></a></td>
        <td name="td6"><a href="https://www.ncbi.nlm.nih.gov/gene/5054" target="_blank" style="color:#520049"><b>5054</b></a></td>
      </tr>
	  </tbody>
  </table>

  <p>Some isolated sequences bind to the affinity of the protein.</p>
<table class="table table-bordered" style="table-layout:fixed;width:auto;margin-left:auto;margin-right:auto;" >
  <thead>
      <tr>
        <th onclick="sortTable(0)">Name</th>
        <th onclick="sortTable(1)">Sequence</th>
        <th onclick="sortTable(2)">Ligand</th>
        <th onclick="sortTable(3)">Affinity</th>
      </tr>
  </thead>
    <tbody>
      <tr>
        <td name="td0">WT-15</td>
        <td name="td1">5'-GGGAGGACGAUGCGGAUCAACUCACCGUAGGUCUAGUGAGAACUUCAAGUCUACUCAGACGACUCGCUGAGGAUCC-3'</td>
        <td name="td2">Serine protease inhibitor plasminogen activator inhibitor-1 (PAI-1)</td>
        <td name="td3">177 pM</td>
      </tr>
	  </tbody>
  </table>
<div style="display: flex; justify-content: center;"></div>
<img src="/images/SELEX_ligand/WT-15_SELEX_ligand.svg" alt="drawing" style="width:1000px;border:solid 1px #efefef;display:block;margin:0 auto;border-radius:0;" class="img-responsive">
<div style="display: flex; justify-content: center;"></div>
<br>


<p class="blowheader_box">Similar compound</p>                    
<p>We used the Dail server website to compare the structural similarities of ligand proteins, and chose the top 10 in terms of similarity for presentation. The Dali server is a network service for comparing protein structures in 3D. Dali compares them against those in the Protein Data Bank (PDB). Z-score is a standard score that is converted from an original score. The list of neighbours is sorted by Z-score. Similarities with a Z-score lower than 2 are spurious. RMSD(Root Mean Square Deviation) value is used to measure the degree to which atoms deviate from the alignment position.</p>
<table class="table table-bordered" style="table-layout:fixed;width:auto;margin-left:auto;margin-right:auto;">
      <thead>
      <tr>
        <th onclick="sortTable(0)">PDB</th>
        <th onclick="sortTable(1)">Z-socre</th>
        <th onclick="sortTable(2)">RMSD</th>
        <th onclick="sortTable(3)">Description</th>
      </tr>
      </thead>
    <tbody>
     <tr>
      <td name="td0">4DY0-B</td>
      <td name="td1">50.5</td>
      <td name="td2">1.7</td>
      <td name="td3">Glia-derived nexin</td>
    </tr>
            
     <tr>
      <td name="td0">4DY7-F</td>
      <td name="td1">50.1</td>
      <td name="td2">2.0</td>
      <td name="td3">Thrombin light chain</td>
    </tr>
            
     <tr>
      <td name="td0">4DY7-C</td>
      <td name="td1">50.1</td>
      <td name="td2">1.9</td>
      <td name="td3">Thrombin light chain</td>
    </tr>
            
     <tr>
      <td name="td0">3Q03-B</td>
      <td name="td1">50.0</td>
      <td name="td2">1.3</td>
      <td name="td3">Plasminogen activator inhibitor 1</td>
    </tr>
            
     <tr>
      <td name="td0">3Q02-A</td>
      <td name="td1">49.9</td>
      <td name="td2">1.3</td>
      <td name="td3">Plasminogen activator inhibitor 1</td>
    </tr>
            
     <tr>
      <td name="td0">6GWN-A</td>
      <td name="td1">49.6</td>
      <td name="td2">1.4</td>
      <td name="td3">Plasminogen activator inhibitor 1</td>
    </tr>
            
     <tr>
      <td name="td0">3Q03-A</td>
      <td name="td1">49.6</td>
      <td name="td2">1.4</td>
      <td name="td3">Plasminogen activator inhibitor 1</td>
    </tr>
            
     <tr>
      <td name="td0">4G8R-A</td>
      <td name="td1">49.4</td>
      <td name="td2">1.4</td>
      <td name="td3">Plasminogen activator inhibitor 1</td>
    </tr>
            
     <tr>
      <td name="td0">3PB1-I</td>
      <td name="td1">49.4</td>
      <td name="td2">1.6</td>
      <td name="td3">Plasminogen activator inhibitor 1</td>
    </tr>
            
     <tr>
      <td name="td0">1DB2-A</td>
      <td name="td1">49.4</td>
      <td name="td2">1.6</td>
      <td name="td3">Plasminogen activator inhibitor 1</td>
    </tr>
    </tbody>
  </table>


                 
<p class="header_box" id="references">References</p>
                
<a id="ref1"></a><font><strong>[1] Endothelial cells produce a latent inhibitor of plasminogen activators that can be activated by denaturants.</strong></font><br />
Hekman, C. M., & Loskutoff, D. J.<br />
<a href="https://pubmed.ncbi.nlm.nih.gov/3930479/" target="_blank" style="color:#520049">The Journal of biological chemistry, 260(21), 11581–11587. (1985)</a>
<br/>
            
<a id="ref2"></a><font><strong>[2] Purification and characterization of a plasminogen activator inhibitor 1 binding protein from human plasma. Identification as a multimeric form of S protein (vitronectin). </strong></font><br />
Declerck, P. J., De Mol, M., Alessi, M. C., Baudner, S., Pâques, E. P., Preissner, K. T., Müller-Berghaus, G., & Collen, D.<br />
<a href="https://pubmed.ncbi.nlm.nih.gov/2459123/" target="_blank" style="color:#520049">The Journal of biological chemistry, 263(30), 15454–15461. (1988)</a>
<br/>
            
<a id="ref3"></a><font><strong>[3] Structural and functional analysis of the plasminogen activator inhibitor-1 binding motif in the somatomedin B domain of vitronectin.</strong></font><br />
Deng, G., Royle, G., Wang, S., Crain, K., & Loskutoff, D. J.<br />
<a href="https://pubmed.ncbi.nlm.nih.gov/8662688/" target="_blank" style="color:#520049">The Journal of biological chemistry, 271(22), 12716–12723. (1996)</a>
<br/>
            
<a id="ref4"></a><font><strong>[4] Plasminogen activator inhibitor-1 represses integrin- and vitronectin-mediated cell migration independently of its function as an inhibitor of plasminogen activation.</strong></font><br />
Kjøller, L., Kanse, S. M., Kirkegaard, T., Rodenburg, K. W., Rønne, E., Goodman, S. L., Preissner, K. T., Ossowski, L., & Andreasen, P. A.<br />
<a href="https://pubmed.ncbi.nlm.nih.gov/9168821/" target="_blank" style="color:#520049">Experimental cell research, 232(2), 420–429. (1997)</a>
<br/>
            
<a id="ref5"></a><font><strong>[5] Plasminogen activator inhibitor type-1: its structure, biological activity and role in tumorigenesis (Review).</strong></font><br />
Chorostowska-Wynimko, J., Skrzypczak-Jankun, E., & Jankun, J.<br />
<a href="https://pubmed.ncbi.nlm.nih.gov/15138609/" target="_blank" style="color:#520049">International journal of molecular medicine, 13(6), 759–766. (2004)</a>
<br/>
            
<a id="ref6"></a><font><strong>[6] Antimetastatic potential of PAI-1-specific RNA aptamers.</strong></font><br />
Blake, C. M., Sullenger, B. A., Lawrence, D. A., & Fortenberry, Y. M.<br />
<a href="https://pubmed.ncbi.nlm.nih.gov/19284310/" target="_blank" style="color:#520049">Oligonucleotides, 19(2), 117–128. (2009)</a>
<br/>



<html lang="en">
    <head>
      <meta charset="utf-8" />
      <meta name="viewport" content="width=device-width, user-scalable=no, minimum-scale=1.0, maximum-scale=1.0">
      <meta http-equiv="X-UA-Compatible" content="IE=edge">
      <!-- Molstar CSS & JS -->
      <link rel="stylesheet" type="text/css" href="https://www.ebi.ac.uk/pdbe/pdb-component-library/css/pdbe-molstar-1.2.1.css">
      <script src="/js/mol/ro_pdbe-molstar-plugin-1.2.1.js"></script>
        <style>
          * {
              margin: 0;
              padding: 0;
              box-sizing: border-box;
          }
          .msp-plugin ::-webkit-scrollbar-thumb {
              background-color: #474748  !important;
          }
          .msp-plugin .msp-layout-standard {
              border: 1px solid #efefef;
          }
          .viewerSection1 {
            padding-top: 0px;
          }
          .controlsSection1 {
            width: 300px;
              display: flex;
              float:left;
              padding: 0px 0 0 0;
              height:25px;
            }
            .controlBox1 {
              border: 0px solid lightgray;
              padding: 0px;
              margin-bottom: 0px;
            }
          #myViewer1{
            float:left;
            width:500px;
            height: 500px;
            position:relative;
          }
        </style>
    </head>
    <script>
      var viewerInstance1 = new PDBeMolstarPlugin();
      var options1 = {
        customData:{
        format: 'pdb'},
        hideCanvasControls: ['expand', 'selection', 'animation', 'controlToggle'],
        bgColor: {r:255, g:255, b:255},
        }
      var viewerContainer1 = document.getElementById('myViewer1');
      viewerInstance1.render(viewerContainer1, options1);
  window.addEventListener('load', function() {
    var colorSelectionButton1 = document.querySelector('.controlsSection1 button');
    colorSelectionButton1.click();
  });
    </script>




    </html>
